Cancer drug cures COVID-19 patient with acute respiratory distress
A cancer drug called ruxolitinib was used to treat a COVID-19 patient with acute respiratory distress, resulting in clinical stabilization and rapid improvement in respiration and heart function. The treatment's success has led to the approval of a clinical trial to test its effect on additional COVID-19 patients.